Figure S1: PMCA-induced α-synuclein fibrillization can occur under non-toxic conditions. Lyophilized recombinant wild-type protein was reconstituted in PCB, PBS, PBSN, TBS or TBSN and subjected to PMCA for a total process time of 24 h. Equivalent samples not subjected to PMCA (-80 o C) served as the non-PMCA monomeric controls. Extent of fibrillization in PMCA-exposed samples was assessed using (A) ThT fluorescence, where the values obtained for each experimental replicate represented the average fluorescence of triplicate wells after subtraction of a blank well to account for background fluorescence (RFU= relative fluorescent units). Data are presented as mean±SEM (n=3) and represent every experimental replicate performed. (B) Western immunoblot analysis using αsynuclein-specific monoclonal antibody MJFR1 (amino acid specificity: 118-123) n=1.
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Figure S3
Figure S3: PBSN buffer is non-toxic to non-transgenic and α-synuclein overexpressing SH-SY5Y neuroblastoma cells (A4). SH-SY5Y cells were stably transfected with human wild-type α-synuclein. The single cell colony, A4, was shown to express elevated levels of α-synuclein compared to untransfected SH-SY5Y cells via (A) western immunoblot and (B) immunofluorescence using αsynuclein-specific monoclonal antibody MJFR1 (amino acid specificity: 118-123). (C,E) Toxicity of PCB and PBSN in untransfected SH-SY5Y and A4 cells after 24 h was measured by assessing LDH levels via absorbance. Values were expressed as a percent cytotoxicity compared to equivalent cells treated with lysis buffer (maximum cell death). Deduction of water treated samples accounted for spontaneous LDH release. All buffers were measured using triplicate reads. Data are presented as mean±SEM (n=3) and represent every experimental replicate performed. (D,F) Following treatment with PBSN or PCB DIC images of cells were taken. n=1, representative images. 
